Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Regenerative Medicine
  4. Use of Self-Complementary Adeno-Associated Virus Serotype 2 as a Tracer for Labeling Axons: Implications for Axon Regeneration

Use of Self-Complementary Adeno-Associated Virus Serotype 2 as a Tracer for Labeling Axons: Implications for Axon Regeneration

PLoS ONE, 2014 · DOI: 10.1371/journal.pone.0087447 · Published: February 3, 2014

Regenerative MedicineNeurologyGenetics

Simple Explanation

Researchers explored viral vectors to study axon regeneration after injury, focusing on self-complementary Adeno-Associated Virus (scAAV). They found scAAV2-GFP effectively labels long-projection axons in the corticospinal tract (CST), rubrospinal tract (RST), and central axons of dorsal root ganglion (DRG) in normal and lesioned animal models. The study compared scAAV2 with single-stranded (ss) AAV2 vectors. Results showed scAAV2 induced faster and stronger transgene expression in DRG neurons and their axons, highlighting its efficiency. In spinal cord lesion and dorsal root crush injury models, scAAV-GFP effectively labeled lesioned and regenerated axons near the lesion cavity and dorsal root entry zone (DREZ), demonstrating its potential for tracing axon regeneration after injury.

Study Duration
2-8 Weeks
Participants
25 adult Fischer 344 rats
Evidence Level
Not specified

Key Findings

  • 1
    scAAV2-GFP efficiently transduces neurons in the sensorimotor cortex, red nucleus, and DRG, with strong GFP expression transported anterogradely along axons to label numerous axon fibers from CST, RST, and central axons of DRG.
  • 2
    scAAV2 vector induces faster and stronger transgene expression than the ssAAV2 vector in DRG neurons and their axons, as shown in co-labeled sections.
  • 3
    scAAV-GFP efficiently labels lesioned and regenerated axons around the lesion cavity and the dorsal root entry zone (DREZ) in spinal cord lesion and dorsal root crush injury models.

Research Summary

This study introduces the use of self-complementary adeno-associated virus serotype 2 (scAAV2) as an effective tracer for labeling axons, demonstrating its ability to efficiently transduce neurons and anterogradely transport GFP to label long axonal tracts like the corticospinal tract (CST), rubrospinal tract (RST), and dorsal root ganglion (DRG) axons. The research compares scAAV2-GFP with single-stranded AAV2 vectors, revealing that scAAV2 induces faster and stronger transgene expression, making it a superior tool for axonal tracing, particularly in small tissues within the central nervous system (CNS). The study demonstrates the utility of scAAV2-GFP in visualizing axonal regeneration in injury models, showing its ability to label lesioned and regenerated axons and its potential for combination with traditional tracers to distinguish between sensory and motor axons.

Practical Implications

Enhanced Axon Tracing

scAAV2-GFP offers a more effective and efficient method for studying axon regeneration compared to traditional tracers, reducing the need for time-consuming procedures and minimizing non-specific labeling.

Improved Gene Therapy

The faster and stronger transgene expression of scAAV2 vectors can minimize the required viral load, potentially reducing the risk of adverse effects in gene therapy applications for CNS disorders.

Combination with Therapeutic Genes

The scAAV2-GFP axon tracing technique can be combined with the expression of axonal growth-promoting genes, allowing for direct and precise assessment of transgene effects on axon regeneration.

Study Limitations

  • 1
    The study did not compare the temporal expression profile or cellular tropism of different AAV serotype vectors.
  • 2
    Weak GFP expression in individual fibers or higher background may require using a GFP specific antibody.
  • 3
    Retrograde transport of AAV vectors can occur, potentially leading to labeling of unintended neuronal populations.

Your Feedback

Was this summary helpful?

Back to Regenerative Medicine